Neuralink has recently garnered attention due to its advancements in brain-machine interface technology and its ongoing clinical trials. The company announced a trial aimed at enabling patients to control robotic limbs using their Neuralink implants, showcasing the potential of its technology to assist individuals with paralysis. Additionally, reports surfaced about the stability of the wires connecting the first patient’s brain to the implant, following previous concerns about detachment. These developments highlight Neuralink's commitment to addressing technical challenges while pushing the boundaries of neurotechnology.
Founded in 2016 by Elon Musk and a group of engineers and scientists, Neuralink Corporation is focused on developing implantable brain-machine interfaces (BMIs). Headquartered in San Francisco, the company aims to create devices that facilitate direct communication between the brain and external devices, potentially revolutionizing treatment for neurological conditions and enhancing human capabilities. Neuralink's vision includes not only medical applications but also the long-term goal of merging human cognition with artificial intelligence.
-
Elon Musk's parenting decisions have sparked controversy, particularly regarding his relationship with Ashley St. Clair, who claims he fathered her child. Reports reveal Musk's extreme views on procreation and his attempts to manage public perception through financial agreements and secrecy. The implications of his actions raise questions about societal values and reproductive rights.
-
A Senate report reveals Elon Musk and his companies face at least $2.37 billion in potential liabilities due to federal investigations and regulatory actions. The report highlights concerns over Musk's conflicts of interest as head of the Department of Government Efficiency (DOGE), suggesting he may evade oversight and legal accountability.
-
At the Saudi-US Investment Forum, Elon Musk announced Starlink's approval for maritime and aviation use, emphasizing its rapid growth. The deal highlights Musk's ongoing influence and connections with the Trump administration, raising concerns about potential conflicts of interest and the implications for U.S. foreign policy.
-
Elon Musk's companies, Neuralink and SpaceX, have secured significant deals in the Middle East during Trump's recent state visit. Neuralink will conduct its first clinical trial in Abu Dhabi, while SpaceX aims to provide satellite internet services in Saudi Arabia and to Emirates Airlines.
-
Elon Musk announced at the Qatar Economic Forum that he will significantly reduce his political contributions, stating, 'I think I’ve done enough.' This decision follows backlash from his political involvement, particularly during the Trump administration, which has negatively impacted Tesla's sales and public perception.
-
Neuralink has raised $500 million in a Series E funding round, valuing the company at approximately $9 billion. The funding will support its brain chip technology, which has shown promise in human clinical trials for patients with severe paralysis. The company recently received breakthrough device designation from the FDA.
-
Elon Musk is raising over $3.5 billion in debt for xAI, with a double-digit interest rate, to fund AI infrastructure, including a major data center in Memphis. This comes as Musk shifts focus back to his businesses after stepping back from political involvement.
-
Neuralink has successfully raised a Series E funding round, attracting major investors like ARK Invest and Sequoia Capital. This follows significant advancements in their brain chip technology, including human clinical trials for patients with severe paralysis. The company is now valued at approximately $9 billion.
-
Walt Disney's granddaughter, Joanna Miller, has criticized the creation of an animatronic version of her grandfather for Disneyland's 70th anniversary. She argues that the portrayal is dehumanizing and does not honor his legacy, expressing her concerns directly to Disney CEO Bob Iger.
-
Neuralink's new device, Blindsight, has demonstrated the ability to stimulate visual processing in monkeys, with two-thirds of trials showing eye movement towards visual stimuli. This marks a significant step in brain-computer interface technology, which aims to treat conditions like ALS and enhance cognitive functions.
-
Edward Coristine, a former DOGE team member, has joined the Social Security Administration as a special government employee. His role focuses on enhancing the agency's website functionality. This follows a tumultuous period marked by leadership changes and controversies surrounding data access at the agency.
-
Researchers have developed a tool that measures biological aging and predicts chronic disease risks using a single brain MRI scan. This innovation, stemming from a collaboration between Duke, Harvard, and the University of Otago, could enable early lifestyle interventions to prevent health issues like dementia.